Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies

Therapeutic monoclonal antibodies (mAbs), including immune checkpoint inhibitors (ICIs), are an important breakthrough for the treatment of cancer and have dramatically changed clinical outcomes in a wide variety of tumours. However, clinical response varies among patients receiving mAb-based treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Mata-Molanes, Juan J., Rebollo-Liceaga, Joseba, Martínez-Navarro, Elena Mª, Manzano, Ramón González, Brugarolas, Antonio, Juan, Manel, Sureda, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263556/
https://www.ncbi.nlm.nih.gov/pubmed/35814459
http://dx.doi.org/10.3389/fonc.2022.926289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263556/
https://www.ncbi.nlm.nih.gov/pubmed/35814459
http://dx.doi.org/10.3389/fonc.2022.926289

Ejemplares similares